A randomized, controlled trial shows improved glycemic control with CGM versus blood glucose monitoring.
Adolescents and young adults have the poorest glycemic control among individuals with type 1 diabetes (T1D). Continuous glucose monitoring (CGM) has been shown effective in improving glycemic control in adults and children but not in adolescents and young adults, among whom CGM use remains low.
In a randomized, controlled trial, researchers compared the efficacy of CGM with that of standard blood glucose monitoring in 153 adolescents and young adults with suboptimal control of T1D. Participants were aged 14 to 24 years (mean age, 17) and were enrolled from 14 U.S. pediatric diabetes centers. Change in hemoglobin A1c (HbA1c) at 26 weeks was the primary outcome.
The CGM group showed improvement in mean HbA1c (8.9% at baseline to 8.5% at 26 week…
Reviewing Author
DisclosuresConsultant/Advisory BoardEli Lilly and Company; Advisory Council, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Subboard for Adolescent Medicine, American Board of Pediatrics
Grant/Research SupportPatty Brisben Foundation
Editorial BoardsOsteoporosis International; Bone; Journal of Adolescent Health
DisclosuresConsultant/Advisory BoardEli Lilly and Company; Advisory Council, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Subboard for Adolescent Medicine, American Board of Pediatrics
Grant/Research SupportPatty Brisben Foundation
Editorial BoardsOsteoporosis International; Bone; Journal of Adolescent Health